1-aminoindan has been researched along with azilect in 1 studies
| Studies (1-aminoindan) | Trials (1-aminoindan) | Recent Studies (post-2010) (1-aminoindan) | Studies (azilect) | Trials (azilect) | Recent Studies (post-2010) (azilect) |
|---|---|---|---|---|---|
| 18 | 0 | 8 | 14 | 0 | 12 |
| Protein | Taxonomy | 1-aminoindan (IC50) | azilect (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.0044 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.412 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.71 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.025 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balogh, B; Chai, CL; Chua, YY; Deme, R; Gölöncsér, F; Ho, HK; Huleatt, PB; Khoo, ML; Liew, RS; Magyar, K; Mátyus, P; Sheela, DP; Sperlágh, B; Tan, TW | 1 |
1 other study(ies) available for 1-aminoindan and azilect
| Article | Year |
|---|---|
Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Mice; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Pargyline; Parkinson Disease; PC12 Cells; Propylamines; Rats; Structure-Activity Relationship | 2015 |